Objective: To investigate the factors that influence the hearing level in Meniere’s disease patients.
Materials and methods: A retrospective study was conducted using the medical records of 60 patients with
Meniere’s disease who were treated in our hospital between January 2004 and December 2015.
Results: The study population was 35.0% male and 65.0% female. The average age of the patients was 50.5
(range 20–74) years old. The age distribution showed a peak at 40 years. The patients who were treated for more
than 2000 days showed significantly increased hearing thresholds compared with those of the patients who were
treated for less than 500 days. The patients with vertigo or dizziness showed significantly worsened hearing levels in comparison to those of the patients without these symptoms. Furthermore, the hearing level of the patients
treated with a selective serotonin reuptake inhibitor (SSRI) or ventilation tubes worsened significantly more than
that of the patients without these treatments.
Conclusion: This study revealed that 1) long-standing disease, 2) vertigo or dizziness and 3) treatment with SSRIs or 4) ventilation tubes are important predictors of the hearing level of Meniere’s disease patients.
We describe the case of an 8-month-old girl with bacterial meningitis. We diagnosed her with meningitis, and
she was admitted to our hospital with symptoms of fever and poor general condition. The latex particle agglutination test (LPAT) was positive for Haemophilus influenzae type b, but blood and cerebrospinal fluid (CSF) culture
showed only Streptococcus pneumoniae. The LPAT has the advantages of producing results earlier than traditional
CSF culture and being easy to perform, but it may provide false positives. It is suggested that we need to understand the advantage and disadvantage of each test and interpret the results.